Skip to content
Search

Latest Stories

In a world first, England is set to light up e-cigs on prescription for smokers; role of community pharmacy yet to be known

England could soon become the world’s first country to prescribe e-cigarettes as a medical product to help people stop smoking tobacco products but it is not yet clear what role community pharmacy will play in it.

With health and social care secretary Sajid Javid welcoming the latest step towards licensing process for manufacturers, e-cigarettes could be prescribed on the NHS.


Javid said: “This country continues to be a global leader on healthcare, whether it’s our Covid-19 vaccine rollout saving lives or our innovative public health measures reducing people’s risk of serious illness.

“Opening the door to a licensed e-cigarette prescribed on the NHS has the potential to tackle the stark disparities in smoking rates across the country, helping people stop smoking wherever they live and whatever their background.”

For licensing, the Medicines and Healthcare Products Regulatory Agency (MHRA) has invited manufacturers to submit their products for approval to be prescribed.

The regulator is also publishing updated guidance, paving the way for medicinally licensed e-cigarettes to be prescribed for smokers who wish to quit. Non-smokers and children are strongly advised against using e-cigarettes.

The MHRA approval will enable clinicians to decide on a case-by-case basis whether to prescribe an e-cigarette to NHS patients for smoking cessation.

Community pharmacy's role yet to be known

Pharmacy Business asked both the Department of Health and Social Care and NHS England and NHS Improvement on what role community pharmacy could play once the programme is rolled out.

While DHSC is yet to respond, NHSE&I said it is waiting for approval from the National Institute for Health and Care Excellence (NICE) before it can go ahead with the programme. "We would need to wait for the NICE guidance to come through before planning how this would be delivered," it said via email to Pharmacy Business.

The debate

There has been much debate over the years about whether e-cigarettes should be used for this purpose.

E-cigarettes contain nicotine and are not risk free, but experts from the UK and US opine that their regulated usage is less harmful than smoking, as they do not produce tar or carbon monoxide.

The aerosol used in e-cigarettes contains some potentially harmful chemicals also found in other cigarettes, but are at much lower levels, they say.

Moreover, a medically licensed e-cigarette will have to go through more rigorous safety checks than the ones sold commercially.

A report co-authored by Action on Smoking and Health (ASH) and Cancer Research UK (CRUK) has also recommended providing e-cigarette packs to smokers to help them quit.

In 2020, it was found that e-cigarettes were the most popular product used by smokers trying to quit in England. Amongst those trying to quit smoking, 27.2 per cent uses e-cigarettes while 18.2 per cent use nicotine replacement therapy products such as patches and gum.

Smoking - a big concern

Smoking remains the leading preventable cause of premature deaths with around 6.1 million active smokers in England.

Almost 64,000 people died from smoking in England in 2019 and the Office for Health Improvement and Disparities (OHID) is supporting efforts to improve public health and ensure communities across the country have equal health outcomes.

Besides, the government will soon publish a new Tobacco Control Plan to set out the roadmap for achieving a smoke-free England by 2030.

More For You

GPhC should consider reduced fees for pharmacists non-practising practising, says RPS

RPS responds to GPhC consultation on draft changes to fees

gettyimages

RPS urges GPhC to reduce registration fees for non-practising pharmacists

The Royal Pharmaceutical Society (RPS) has called on the General Pharmaceutical Council (GPhC) to reduce annual registration fees for non-practising pharmacists — such as those on parental leave or with a long-term illness — in response to the regulator’s consultation on proposed changes to fees.

The GPhC is proposing a 6% increase in annual registration fees from September 2025 to cover the rising operational costs.

Keep ReadingShow less
Nick Kaye
Nick Kaye appointed as NPA's new chair
Nick Kaye appointed as NPA's new chair

Breaking news: NPA members advised against collective action

With the government’s recent announcement of increased funding to the sector signalling a ‘clear step forward’, the National Pharmacy Association (NPA) has today announced that it will not be recommending collective action to its members.

Last month, the department of health announced the Community Pharmacy Contractual Framework (CPCF) with an increase in funding for 2024/25 of £106m to £2.7 billion and simultaneously a further increase to £3.1 billion for 25/26.

Keep ReadingShow less
Slamannan Village Pharmacy sold after 31 years

Slamannan Village Pharmacy

Slamannan Village Pharmacy sold after 31 years

A pharmacy in a small village in Scotland that has served its community for 31 years, has been bought by a group that operates 43 pharmacies across Scotland.

Slamannan Village Pharmacy is heavily relied on by locals sourcing their prescriptions from the village’s sole GP surgery.

Keep ReadingShow less
Kinnock highlights employers’ role in making community pharmacy jobs attractive

The new funding uplift our commitment to rebuilding the sector: Kinnock

Kinnock: ‘Employers have a key role in making community pharmacy jobs attractive’

Health minister Stephen Kinnock has emphasised that employers have a crucial role to play in retaining staff and making careers in community pharmacy more attractive.

His comments came in response to a written question from Victoria Collins MP, the Liberal Democrat spokesperson for science and technology, who asked what steps the Department of Health and Social Care is taking to address staff shortages and prevent the closure of local pharmacies.

Keep ReadingShow less
​Pope Francis

Pope Francis at the Vatican on December 4, 2024.

Photo by FILIPPO MONTEFORTE/AFP via Getty Images

His Holiness Mahant Swami Maharaj offers condolences to Catholic community following Pope Francis' passing

His Holiness Mahant Swami Maharaj, the spiritual leader and president of the Bochasanwasi Akshar Purushottam Swaminarayan Sanstha (BAPS), has expressed heartfelt condolences to the Catholic community worldwide following the passing of Pope Francis on Monday.

In a formal letter addressed to the members of the Roman Catholic Church, Mahant Swami Maharaj conveyed the deep sorrow of the BAPS Swaminarayan Hindu fellowship, acknowledging the Pope's passing as “a profound loss to the Catholic community and Christians around the world.”

Keep ReadingShow less